Literature DB >> 7226105

Changes in clinical presentation and management of malignant melanoma.

F H Bagley, B Cady, A Lee, M A Legg.   

Abstract

Records of 147 patients with primary cutaneous malignant melanoma treated at the Lahey Clinic from 1955--1979 were reviewed. Complete clinical follow-up data were obtained, and all pathologic material was reviewed. Proposed new risk categories based on a modification of the Clark and Breslow categorizations are outlined. The incidence of low-risk melanoma has dramatically increased (from 23--53%) and that of high-risk melanoma has decreased (from 34--10%) over the period of this study. Dermal punch biopsy gives accurate staging information and carries no increased risk of local recurrence, nodal metastases, or death from disease. Resection of a margin of clinically uninvolved skin measuring twice the diameter of the primary melanoma minimizes local recurrence (2.5% or less), does not adversely affect survival, and reduces the need for skin grafting. Arbitrary wide margins are not justified. Regional lymphadenectomy offers no improvement in survival in patients with low-risk and moderate-risk melanoma and can play only a minor role at most in improving survival for patients with high-risk melanoma.

Entities:  

Mesh:

Year:  1981        PMID: 7226105     DOI: 10.1002/1097-0142(19810501)47:9<2126::aid-cncr2820470904>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  At least one centimetre for each millimetre.

Authors:  F H Rampen
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-29

Review 2.  Surgical management of primary melanoma.

Authors:  D Costello; A Powers; J Lynn; C W Cruse; D Reintgen
Journal:  Curr Oncol Rep       Date:  2000-07       Impact factor: 5.075

3.  Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression.

Authors:  H J Wanebo; P H Cooper; R W Hagar
Journal:  Ann Surg       Date:  1985-04       Impact factor: 12.969

4.  The extent of primary melanoma excision. A re-evaluation--how wide is wide?

Authors:  D R Aitken; K Clausen; J P Klein; A G James
Journal:  Ann Surg       Date:  1983-11       Impact factor: 12.969

5.  Judging prognosis in malignant melanoma of the skin. A problem of inference over small data sets.

Authors:  M S Blois; R W Sagebiel; M S Tuttle; T M Caldwell; H W Taylor
Journal:  Ann Surg       Date:  1983-08       Impact factor: 12.969

6.  The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma.

Authors:  J W Kelly; R W Sagebiel; W Calderon; L Murillo; R L Dakin; M S Blois
Journal:  Ann Surg       Date:  1984-12       Impact factor: 12.969

7.  Chromosome 9p deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside the p16 (CDKN2) gene.

Authors:  S Puig; A Ruiz; C Lázaro; T Castel; M Lynch; J Palou; A Vilalta; J Weissenbach; J M Mascaro; X Estivill
Journal:  Am J Hum Genet       Date:  1995-08       Impact factor: 11.025

8.  Malignant melanoma--profile of an epidemic.

Authors:  R M Rifkin; M R Thomas; T I Mughal; J S Kaur; L U Krebs; W A Robinson
Journal:  West J Med       Date:  1988-07

9.  Excision biopsy of malignant melanoma by general practitioners in south east Scotland 1982-91.

Authors:  R M Herd; J A Hunter; K M McLaren; U Chetty; A C Watson; J M Gollock
Journal:  BMJ       Date:  1992-12-12

10.  Trends in tumour characteristics and survival of malignant melanoma 1960-84: a population-based study in Sweden.

Authors:  M Thörn; F Pontén; R Bergström; P Sparén; H O Adami
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.